November 27, 2025 - 23:11

Recent research has revealed that advanced AI chatbots can play a significant role in reducing belief in antisemitic conspiracy theories. The study highlights the effectiveness of these chatbots in engaging users in meaningful conversations, challenging harmful narratives, and promoting factual information.
As antisemitism and hate speech continue to be pressing issues in society, the ability of AI technology to counteract these beliefs could represent a significant breakthrough. The chatbots utilize natural language processing to understand and respond to users' queries, providing them with accurate information and encouraging critical thinking.
Participants in the study reported a notable decrease in their acceptance of antisemitic conspiracies after interacting with the AI chatbots. This finding underscores the potential for technology to serve as a tool for education and awareness, fostering a more informed public. With ongoing advancements in AI, the hope is that such tools can be further developed to combat various forms of hate speech effectively.
August 9, 2026 - 18:31
County agenda features tax, technology and fairgroundsThe meeting will center on how to fund the ongoing fairgrounds project, a long-discussed priority for the county. Officials are expected to review the latest cost estimates and possible revenue...
August 9, 2026 - 00:24
‘AI slop’ crackdown: LinkedIn, Snap target low-quality gen-AI contentSocial platforms are starting to push back against the flood of generic, machine-generated posts, but they are doing so carefully. LinkedIn and Snap have both announced new measures aimed at...
August 8, 2026 - 05:47
Why GigaCloud Technology (GCT) Is Up 21.7% After Strong Q2 Results And New Buyback PlanGigaCloud Technology saw its stock surge 21.7% in early trading following the release of its second-quarter financial results and the announcement of a new capital return program. The company...
August 7, 2026 - 22:40
As FDA Approves First-Ever mRNA Flu Vaccine For Older Adults, Past KFF Polling Showed Most In This Age Group Were Uncertain About the Technology’s SafetyOn August 5, 2026, the U.S. Food and Drug Administration gave the green light to the first messenger RNA flu vaccine for adults aged 50 and older. The decision came after a clinical trial involving...